Fibroheal Woundcare key facts
as of Oct 2026- Developer of active wound care products intended to heal acute and chronic wounds or non-healing wounds through indigenously developed intellectual property-protected technology.
- Fibroheal Woundcare is valued at approximately $5.2M as of Oct 2026 (last reported valuation).
- It has raised $14.1M; the latest was Later Stage VC ($12.0M) in Dec 2024.
- Notable investors include BIRAC, Telama Investments, Abishek Vijaykumar, Centre for Cellular And Molecular Platforms, Joseph James — 9 tracked in total.
- Status: Privately Held (backing).
Fibroheal Woundcare's last reported valuation, Dec 2024. Nothing priced has surfaced since.
- ·Watch Fibroheal Woundcare: the Monday email on marks, rounds and moves
Fibroheal Woundcare funding rounds
No funding rounds for Fibroheal Woundcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Fibroheal Woundcare valuation
Fibroheal Woundcare's last reported valuation was $5.2 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.
Fibroheal Woundcare investors
9 investors are on record for Fibroheal Woundcare, including BIRAC, Telama Investments, Abishek Vijaykumar and Centre for Cellular And Molecular Platforms.
About Fibroheal Woundcare
Developer of active wound care products intended to heal acute and chronic wounds or non-healing wounds through indigenously developed intellectual property-protected technology. The company uses the biomaterial property of silk and silk protein to provide wound care management for acute, chronic, surgical and traumatic wounds as well as address post-operative dressings, enabling wound care professionals in both institutional and customer segments to have access to advanced, affordable and effective wound care services for all types and stages of wounds.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2017
- Employees
- 72
- Website
- fibroheal.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.